美国远程医疗公司Hims & Hers Health（股票代码：HIMS）于周一发布了2025年第一季度财报，尽管业绩超出市场预期，但夜盘交易中股价却大跌5.06%，引发投资者关注。
财报显示，Hims & Hers Health第一季度调整后每股收益达0.20美元，远超分析师预期的0.12美元，同比增长300%。公司季度营收同比增长110.7%，达到5.8601亿美元，同样高于市场预期的5.3820亿美元。然而，公司给出的第二季度营收指引为5.3亿至5.5亿美元，低于分析师预期的5.646亿美元。
尽管公司重申了2025年全年收入指引为23亿至24亿美元，但投资者似乎对其未来增长前景持谨慎态度。值得注意的是，Hims & Hers Health的股价在本季度已上涨38.1%，今年迄今为止更是累计上涨68.8%。夜盘股价的下跌可能反映了部分投资者选择获利了结，也可能暗示市场对公司能否持续保持如此高速增长存在疑虑。分析师目前对该公司股票的平均评级为"持有"，未来股价走势值得进一步关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.